Administration, Intravenous
"Administration, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of substances through VENIPUNCTURE into the VEINS.
| Descriptor ID |
D061605
|
| MeSH Number(s) |
E02.319.267.082
|
| Concept/Terms |
Administration, Intravenous- Administration, Intravenous
- Administrations, Intravenous
- Intravenous Administrations
- Intravenous Administration
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravenous".
This graph shows the total number of publications written about "Administration, Intravenous" by people in this website by year, and whether "Administration, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 9 | 9 |
| 2016 | 1 | 10 | 11 |
| 2017 | 1 | 11 | 12 |
| 2018 | 1 | 12 | 13 |
| 2019 | 1 | 10 | 11 |
| 2020 | 1 | 7 | 8 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 6 | 6 |
| 2024 | 0 | 4 | 4 |
| 2025 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravenous" by people in Profiles.
-
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial. J Antimicrob Chemother. 2025 Oct 03; 80(10):2719-2726.
-
Comparing the Cognitive Effects of Repeated Intravenous Ketamine and Electroconvulsive Therapy in Patients With Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial. J Clin Psychiatry. 2025 Sep 03; 86(4).
-
A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy. Pharmacotherapy. 2025 Aug; 45(8):504-511.
-
A phase 2 trial of short-term intravenous N-acetylcysteine in biliary atresia after Kasai portoenterostomy. Hepatol Commun. 2025 Jul 01; 9(7).
-
Intraosseous vs Intravenous Access for Epinephrine in Pediatric Out-of-Hospital Cardiac Arrest. JAMA Netw Open. 2025 06 02; 8(6):e2517291.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc. 2024 Dec 30; 13(12):633-638.
-
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data. Parkinsonism Relat Disord. 2025 Mar; 132:107257.
-
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study. J Rheumatol. 2024 Nov 01; 51(11):1125-1134.
-
Use of Early Intravenous Beta Blockers in Patients with Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure-Revival or Requiem? Cardiovasc Drugs Ther. 2024 Oct; 38(5):973-975.